December 13, 2024 18:39 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
US drug agency says COVID-19 vaccine may be authorized before end of phase 3 trials

US drug agency says COVID-19 vaccine may be authorized before end of phase 3 trials

Aug 31, 2020, at 03:09 am

Washington/Sputnik: The US Food and Drug Administration (FDA) is ready to authorize a vaccine against COVID-19 before the end of phase three clinical trials if such a move proves to bring more benefits than risks, Stephen Hahn, the head of the FDA, told the Financial Times (FT) in an interview, which was published on Sunday.

Glenmark to conduct clinical trials in India for potential COVID-19 drug

Glenmark to conduct clinical trials in India for potential COVID-19 drug

Apr 30, 2020, at 04:58 pm

New Delhi/IBNS: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, on Thursday announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India to conduct clinical trials on Favipiravir Antiviral tablets on COVID-19 patients.